Lateral Lymph Node Metastases in T1a Papillary Thyroid Carcinoma: Stratification by Tumor Location and Size.


Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2021
Historique:
received: 28 05 2021
accepted: 25 06 2021
entrez: 2 8 2021
pubmed: 3 8 2021
medline: 12 2 2022
Statut: epublish

Résumé

To analyze the incidence and risk factors for lateral lymph node metastases (LNMs) in T1a papillary thyroid carcinoma (PTC) with a focus on tumor location and size. The incidence of lateral LNM in 345 cases of T1a PTC was retrospectively analyzed. Univariate and multivariate analyses were performed to assess the relationships between lateral LNM and clinicopathological characteristics. The incidence of skip metastasis to lateral LNM in T1a PTC located in the upper lobe was 12.1% (8/66). Logistic regression analysis indicated tumor size >5 mm (OR = 5.04, 95% CI = 1.79 to 14.18, P = 0.002), upper lobe location (OR = 7.68, 95% CI = 3.05-19.34, P < 0.001) and the number of central neck LNM (<2: OR = 24.79, 95% CI = 8.23-74.60, P < 0.001; ≥2: OR = 4.99, 95% CI = 1.95-12.73, P < 0.001) were independently associated with lateral LNM. Comparing the lateral and central LNM stratification based on tumor location revealed that both the incidences of lateral (33.3%) and central (30.3%) LNM of T1a PTC located in the upper lobe were higher than those of T1a PTC located in the middle and lower lobes. Of T1a PTC located in the upper lobe, the incidence of lateral LNM was 33.3% (22/66), which was higher than that [30.3% (20/66)] of central LNM. This finding is reversed in all T1a PTC cases and T1a PTC cases with tumor located in the middle and lower lobes. A particularly high likelihood of lateral LNM was observed in T1a PTC patients with tumor located in the upper lobe of the thyroid gland, especially the tumor >5 mm in size, which could be considered a risk factor for lateral LNM in the clinical management of T1a PTC.

Identifiants

pubmed: 34335480
doi: 10.3389/fendo.2021.716082
pmc: PMC8320373
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

716082

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2021 Zhang, Chen, Fang, Fan, Feng, Guo, Liu, Ge and Du.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Surgery. 2011 Dec;150(6):1161-7
pubmed: 22136836
Thyroid. 2012 Nov;22(11):1144-52
pubmed: 23083442
World J Surg. 2004 Nov;28(11):1115-21
pubmed: 15490053
N Engl J Med. 2014 Nov 6;371(19):1765-7
pubmed: 25372084
Ann Surg Oncol. 2017 Mar;24(3):739-744
pubmed: 27738849
Surgery. 2019 Jul;166(1):55-60
pubmed: 30876667
JAMA. 2017 Apr 4;317(13):1338-1348
pubmed: 28362912
Surgery. 2014 Jul;156(1):137-46
pubmed: 24878458
Clin Endocrinol (Oxf). 2017 Jun;86(6):845-851
pubmed: 28273370
Thyroid. 2020 Mar;30(3):401-407
pubmed: 31910102
World J Surg. 2018 Jan;42(1):123-129
pubmed: 28779384
Asian J Surg. 2019 Apr;42(4):563-570
pubmed: 30078501
Cancer. 2009 Aug 15;115(16):3801-7
pubmed: 19598221
Oral Oncol. 2017 Sep;72:183-187
pubmed: 28222967
Thyroid. 1999 Feb;9(2):105-11
pubmed: 10090308
World J Surg. 2016 Mar;40(3):529-37
pubmed: 26581368
Endocr Pract. 2019 Feb;25(2):131-137
pubmed: 30383496
Ann Surg Oncol. 2016 Sep;23(9):2866-73
pubmed: 27075321
Ann Surg Oncol. 2019 Nov;26(12):3992-4001
pubmed: 31264121
Ultrasonography. 2019 Jul;38(3):231-235
pubmed: 30690963
Thyroid. 2020 Jul;30(7):1037-1043
pubmed: 31573414
Ann Surg Oncol. 2017 Feb;24(2):460-468
pubmed: 27654105
Pathol Oncol Res. 2019 Jul;25(3):1245-1251
pubmed: 30361912
Endocr J. 1999 Feb;46(1):209-16
pubmed: 10426589
Clin Endocrinol (Oxf). 2009 Aug;71(2):157-65
pubmed: 19170717
Surgery. 2012 Aug;152(2):145-51
pubmed: 22503316
Endocr J. 2016 Apr 25;63(4):323-8
pubmed: 26632168
Thyroid. 2016 Jan;26(1):1-133
pubmed: 26462967
Ann Surg. 2015 Sep;262(3):519-25; discussion 524-5
pubmed: 26258321
Thyroid. 2014 Feb;24(2):241-4
pubmed: 23713855
Endocrine. 2020 Jul;69(1):149-156
pubmed: 32146654
BMC Cancer. 2019 Jun 25;19(1):622
pubmed: 31238891
Thyroid. 2016 Jan;26(1):144-9
pubmed: 26414743
Thyroid. 2003 Apr;13(4):381-7
pubmed: 12804106
Surgery. 2011 Dec;150(6):1242-9
pubmed: 22136847
Otolaryngol Head Neck Surg. 2012 Jul;147(1):15-9
pubmed: 22399280
Head Neck. 2019 Jul;41(7):2441-2449
pubmed: 30938923

Auteurs

Xiaojun Zhang (X)

Department of Head Neck and Thyroid Surgery, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.

Wenkuan Chen (W)

Department of Head and Neck Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.

Qigen Fang (Q)

Department of Head Neck and Thyroid Surgery, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.

Jie Fan (J)

Department of Head Neck and Thyroid Surgery, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.

Lu Feng (L)

Department of Head Neck and Thyroid Surgery, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.

Lanwei Guo (L)

Office for Cancer Control and Research, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.

Shanting Liu (S)

Department of Head Neck and Thyroid Surgery, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.

Hong Ge (H)

Department of Radiation Oncology, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.

Wei Du (W)

Department of Head Neck and Thyroid Surgery, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH